YieldMax PLTR Option Inco... (PLTY)
AMEX: PLTY
· Real-Time Price · USD
66.45
-1.01 (-1.50%)
At close: Aug 18, 2025, 3:59 PM
66.50
0.08%
After-hours: Aug 18, 2025, 07:59 PM EDT
-1.50% (1D)
Bid | 66.23 |
Market Cap | 559.86M |
AUM | 656.16M |
NAV | 77.88 |
EPS (ttm) | n/a |
PE Ratio (ttm) | n/a |
Shares Out | 8.43M |
Inception Date | Oct 6, 2024 |
Ask | 67.6 |
Volume | 573.85K |
Open | 67.53 |
Previous Close | 67.46 |
Day's Range | 65.52 - 67.66 |
52-Week Range | 46.28 - 95.08 |
Holdings | 0 |
Expense Ratio | 0.99% |
About PLTY
The fund uses a synthetic covered call strategy to provide income and indirect exposure to the share price returns of PLTR, which is generally subject to a limit on potential investment gains as a result of the nature of the options strategy it employs. The fund is non-diversified.
Asset Class Equity
Ticker Symbol PLTY
Inception Date Oct 6, 2024
Provider Yieldmax
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 96.79% of assets
Name | Symbol | Weight |
---|---|---|
Pltr Us 09/19/25 C14... | PLTR 250919C00140000 | 23.38% |
United States Treasu... | 912797QP5 | 22.59% |
United States Treasu... | 91282CFP1 | 19.12% |
United States Treasu... | 912797PM3 | 12.67% |
United States Treasu... | 91282CGE5 | 8.82% |
United States Treasu... | 912797PN1 | 8.20% |
First American Gover... | FGXXX | 1.19% |
Pltr Us 08/15/25 C19... | PLTR 250815C00190000 | 0.40% |
United States Treasu... | 912797RF6 | 0.25% |
Pltr Us 08/15/25 C19... | PLTR 250815C00192500 | 0.17% |
Dividends Dividend Yield 70.55%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Aug 14, 2025 | $7.4924 | Aug 15, 2025 |
Jul 17, 2025 | $2.5602 | Jul 18, 2025 |
Jun 20, 2025 | $3.2600 | Jun 23, 2025 |
May 22, 2025 | $7.0442 | May 23, 2025 |
Apr 24, 2025 | $4.6556 | Apr 25, 2025 |

2 months ago · seekingalpha.com
PLTY: Why I'm Passing On This Ephemerous 147.89% Distribution RateThe YieldMax PLTR Option Income Strategy ETF uses a covered call strategy on volatile stocks like Palantir, offering high distribution rates but not true profits. I'm skeptical these products outperfo...